Celiac disease is classified as an autoimmune disease because eating gluten triggers the immune system to produce antibodies that attack the body’s own tissue, specifically the lining of the small intestine. This is the defining feature of autoimmunity: the immune system mistakenly targets something that belongs to you, not just the foreign substance that started the reaction. About 1% of people in Western countries have celiac disease, and its autoimmune mechanism sets it apart from both wheat allergies and general gluten sensitivity.
What Makes a Disease “Autoimmune”
In a healthy immune system, the body identifies foreign invaders like bacteria or viruses, attacks them, and leaves your own cells alone. In autoimmune diseases, something goes wrong with that targeting. The immune system begins treating the body’s own proteins or tissues as threats, producing antibodies against them and causing inflammation and damage.
Celiac disease fits this pattern precisely. When someone with celiac disease eats gluten, their immune system doesn’t just react to the gluten itself. It also generates antibodies against an enzyme called tissue transglutaminase, which is a normal, healthy protein found throughout the body, especially in the gut lining. That enzyme becomes what immunologists call an “autoantigen,” a piece of your own biology that the immune system has wrongly flagged as dangerous. This self-directed attack is the reason celiac disease is autoimmune and not simply a food intolerance or allergy.
The Step-by-Step Immune Reaction
The process begins when you eat foods containing gluten, a protein found in wheat, rye, and barley. In the gut, tissue transglutaminase chemically modifies fragments of gluten in a way that makes them far more visible and provocative to the immune system. The modified gluten fragments bind tightly to specific immune molecules on the surface of cells, which then present those fragments to immune cells called T cells.
Once activated, these T cells launch an inflammatory response that damages the lining of the small intestine. The tiny, finger-like projections called villi, which absorb nutrients from food, gradually flatten and erode. This damage is graded on a scale called the Marsh classification, ranging from mild inflammation (Marsh 1) to severe flattening of the villi (Marsh 3c). At the same time, the crypts between the villi, where new cells are produced, begin to grow abnormally in a process called crypt hyperplasia.
Meanwhile, the immune system also produces antibodies against tissue transglutaminase itself. This is the autoimmune piece of the puzzle. The enzyme that modified gluten in the first place becomes a target, and the resulting antibodies can cause damage not just in the gut but potentially in other parts of the body where the enzyme is present.
The Role of Genetics
Nearly all people with celiac disease, about 98%, carry one or both of two specific genetic variants known as HLA-DQ2 and HLA-DQ8. Roughly 80% carry HLA-DQ2 alone, about 8% carry only HLA-DQ8, and around 11% carry both. These genes code for the immune molecules that present gluten fragments to T cells. Without them, the autoimmune cascade simply cannot get started.
However, these genes are common in the general population. Around 55% of people without any family history of celiac disease carry HLA-DQ2 or HLA-DQ8, and among relatives of celiac patients the figure rises to nearly 90%. Carrying the genes is necessary but not sufficient. Other factors, still not fully understood, determine whether someone with the genetic predisposition actually develops the disease.
How Celiac Differs From a Wheat Allergy
A wheat allergy and celiac disease both involve the immune system reacting to something in wheat, but the mechanisms are fundamentally different. In a wheat allergy, the body produces a type of antibody called IgE against wheat proteins. This triggers a rapid allergic reaction, the kind that can cause hives, swelling, or in severe cases anaphylaxis, usually within minutes to hours of eating wheat.
Celiac disease involves a completely different arm of the immune system. Instead of IgE antibodies, it is driven by T cells and autoantibodies against the body’s own tissue transglutaminase. The damage is slower, cumulative, and primarily targets the small intestine over weeks and months of ongoing gluten exposure. A person with a wheat allergy can often tolerate rye and barley. A person with celiac disease cannot, because all three grains contain the types of gluten that trigger the autoimmune response.
There is also a third category, non-celiac gluten sensitivity, which causes symptoms after eating gluten but does not appear to involve the autoimmune or allergic mechanisms seen in celiac disease or wheat allergy.
One Unique Feature: It’s Reversible
Celiac disease has an unusual characteristic among autoimmune diseases. The intestinal damage can fully heal when gluten is completely removed from the diet. In most autoimmune conditions, such as type 1 diabetes or rheumatoid arthritis, the immune attack causes permanent damage that cannot be undone by removing a single trigger. In celiac disease, the trigger is known and avoidable, and the mucosal damage, along with the disease’s progression, is reversible with strict gluten avoidance. This makes it one of the few autoimmune diseases that can be managed entirely through diet.
What Happens Without Treatment
When celiac disease goes undiagnosed or untreated, chronic inflammation and villous atrophy impair the gut’s ability to absorb nutrients. This can lead to deficiencies in calcium and vitamin D, contributing to weakened bones. Ongoing autoimmune activity has also been linked to reproductive complications, with celiac autoantibodies potentially interfering with blood vessel formation in the uterine lining.
The most serious long-term risk is a small but real increase in the chance of developing certain cancers, particularly non-Hodgkin lymphoma and intestinal adenocarcinoma. A rare but well-documented complication of refractory celiac disease is a specific type of lymphoma estimated to affect between 0.1% and 3.2% of all celiac patients. The elevated cancer risk is most concerning in people diagnosed later in life, those with a long delay before diagnosis, or those with severe malabsorption.
Links to Other Autoimmune Conditions
People with celiac disease are significantly more likely to develop other autoimmune diseases, and vice versa. The strongest associations are with type 1 diabetes, autoimmune thyroid disease (particularly Hashimoto’s thyroiditis), autoimmune liver disease, Sjögren’s syndrome, and psoriasis.
The overlap with type 1 diabetes is especially well documented. Between 4.4% and 11% of people with type 1 diabetes also have celiac disease, far higher than the roughly 1% prevalence in the general population. In most cases, about 90%, the diabetes diagnosis comes first. One Swedish study that screened children with type 1 diabetes yearly found that 6% developed silent celiac disease over a five-year period. Autoimmune thyroiditis shows a similar pattern: celiac disease is the most common associated autoimmune condition found in people with thyroid autoimmunity, and the relationship works in both directions.
These overlapping conditions likely share genetic roots, particularly in the HLA gene region that governs how the immune system identifies threats. Having one autoimmune disease doesn’t cause another, but the shared genetic susceptibility means the same person is more vulnerable to multiple immune misfires.
How Diagnosis Confirms the Autoimmune Nature
The diagnostic process for celiac disease essentially tests for evidence of autoimmunity. Blood tests measure levels of antibodies against tissue transglutaminase. When those antibody levels are elevated, it indicates the immune system is actively targeting the body’s own enzyme. A biopsy of the small intestine can then confirm whether the characteristic damage, villous atrophy and crypt hyperplasia, is present. A positive blood test paired with villous atrophy on biopsy confirms the diagnosis.
In cases where blood tests and biopsy results don’t align, genetic testing for HLA-DQ2 and HLA-DQ8 can help clarify. If neither gene is present, celiac disease is effectively ruled out. When the diagnosis is confirmed and gluten is removed, the clinical response, healing of the gut lining and disappearance of autoantibodies, further reinforces that the disease was driven by an autoimmune process with gluten as the environmental trigger.